Search

everythinglearnresearchcommunity

for

Search:↓

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Combining cytostatic and steroid drugs effectively treats systemic lupus erythematosus.

Oral retinoids are effective for various skin conditions but have side effects and should not be used during pregnancy.

Some medications can cause reversible hair loss by affecting hair growth cycles.

Skin fungal infections are more common in older adults due to factors like obesity, poor circulation, reduced mobility, and weakened immune defenses from certain medications.

The condition called 'acute diffuse and total alopecia of the female scalp' is actually a known condition named alopecia areata incognita.

Zinc pyrithione in shampoo effectively treats dandruff.

Using a niacinamide cream can improve life quality for breast cancer patients during chemotherapy.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

Topoisomerase inhibitors can cause hair loss, skin rash, hand-foot syndrome, and nail changes.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Nonimmunosuppressive cyclosporines might treat skin diseases by affecting cell growth.

Combining L-cysteine, NAC, and a MET inhibitor significantly kills cervical cancer cells.

IGRT resulted in lower acute toxicity for stage III prostate cancer patients.

A woman developed severe bladder inflammation after cancer treatment with Cytoxan.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Taking selenium supplements during chemotherapy may help reduce side effects and improve health markers in ovarian cancer patients.

Cytarabine can cause multiple organ toxicities, especially neurotoxicity, but better research methods are needed to fully understand and predict these effects.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Endoxan often causes hair loss, which usually starts in the third week of treatment.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Anti-cancer drugs are diverse and hard to classify due to their different forms and actions.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Mannitol diuresis allows higher doses of cis-platinum for testicular cancer treatment without increasing kidney damage.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

Scalp cooling can prevent hair loss in 65% of chemotherapy patients, especially effective in breast cancer patients and certain chemotherapy types.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Hairgain® significantly increased hair growth and was well-tolerated by individuals with hair loss.